Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease | MicrobiomeTrials← Back to trialsNCT06747572
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-12-19Est. Completion: 2026-12-31
Enrollment target: 401 participants Locations- Alabama Kidney Research, Alabaster, Alabama, United States
- University of Alabama at Birmingham- Nephrology Research Clinic, Birmingham, Alabama, United States
- Kaiser Permanente - Los Angeles Medical Center, Los Angeles, California, United States
- UCLA Division of Nephrology, Los Angeles, California, United States
- Helen Diller Medical Center at Parnassus Heights, San Francisco, California, United States
- Nephrology & Hypertension Associates, PC, Middlebury, Connecticut, United States
- Yale Nephrology Clinical Research Clinic, New Haven, Connecticut, United States
- Nature Coast Clinical Research - Inverness, Inverness, Florida, United States
- Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
- Emory School of Medicine - Renal Division, Atlanta, Georgia, United States
- Renal Associates, LLC, Columbus, Georgia, United States
- UChicago Medicine - Duchossois Center for Advanced Medicine - Nephrology, Chicago, Illinois, United States
- University of Iowa Health Care Medical Center- Nephrology, Iowa City, Iowa, United States
- Clinical & Translational Science Unit (CTSU) - Nephrology, Kansas City, Kansas, United States
- General Clinical Research Center, University of Maryland Baltimore, Baltimore, Maryland, United States
- Tufts Medical Center, Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center - Nephrology, Boston, Massachusetts, United States
- Quest Research Institute, Farmington Hills, Michigan, United States
- University of Minnesota -Health Clinical Research Unit, Minneapolis, Minnesota, United States
- Mayo Clinic - Rochester, Rochester, Minnesota, United States
- DaVita Clinical Research, Las Vegas, Nevada, United States
- Columbia University Medical Center, New York, New York, United States
- Geisinger Clinic, Danville, Pennsylvania, United States
Other microbiome trials you might be interested in
Autosomal Dominant Polycystic Kidney
This study will evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of GBP-2…
Shanghai, ChinaEst. completion Jul 2027
Renal Anemia
In this study, the researchers want to learn more about the safety and effectiveness of Molidustat in Japanese men and w…
Multiple Locations, JapanEst. completion Jun 30, 2027
Perelman Center for Advanced Medicine - Nephrology, Philadelphia, Pennsylvania, United StatesNephrology Clinical Trials Center, Nashville, Tennessee, United StatesUVM Medical Center - 1 South Prospect Street, Burlington, Vermont, United StatesSwedish Center for Comprehensive Care, Seattle, Washington, United StatesUniversite Catholique de Louvain, Cliniques universitaires Saint-Luc (UCLouvain), Brussels, BelgiumUniversitaire Ziekenhuizen Leuven, Leuven, BelgiumSt. Joseph's Healthcare - Hamilton, Hamilton, CanadaMUHC - Montreal Children's Hospital, Montreal, CanadaHopital de la Cavale Blanche, Brest, FranceNecker Hospital, Paris, FranceCharité - Klinik für Nephrologie und Intensivmedizin der, Berlin, GermanyUniversitaetsklinik Koeln Department II of Internal Medicine, Cologne, GermanyUMCG - Nephrology, Groningen, NetherlandsErasmus Medisch Centrum - Nephrology, Rotterdam, NetherlandsFDI Clinical Research - San Juan, San Juan, Puerto RicoHospital Fundacion Jimenez Diaz, Madrid, SpainQueen Elizabeth Hospital Birmingham, Birmingham, United KingdomKing's College Hospital, London, United KingdomRoyal Free Hospital - Nephrology, London, United KingdomSt Georges University Hospitals NHS Foundation Trust, London, United KingdomNewcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital - Nephrology, Newcastle upon Tyne, United KingdomNorthern General Hospital, Sheffield, United Kingdom